Correction: Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer

期刊论文
出版模式：

开放获取
发表日期：

2024年3月4日

查看全文

Dana M. Roque,
Eric R. Siegel,
Natalia Buza,
Stefania Bellone,
Dan-Arin Silasi,
Gloria S. Huang,
Vaagn Andikyan,
Mitchell Clark,
Masoud Azodi,
Peter E. Schwartz,
Gautam G. Rao,
Jocelyn C. Reader,
Pei Hui,
Joan R. Tymon-Rosario,
Justin Harold,
Dennis Mauricio,
Burak Zeybek,
Gulden Menderes,
Gary Altwerger,
Elena Ratner,
Alessandro D. Santin

本文未提供摘要，请点击“查看全文”查看完整内容。